Addressing the questions of tomorrow: melphalan and new combinations as conditioning regimens before autologous hematopoietic progenitor cell transplantation in multiple myeloma

Massimo Martino, Attilio Olivieri, Massimo Offidani, Ernesto Vigna, Tiziana Moscato, Roberta Fedele, Mauro Montanari, Giuseppe Console, Massimo Gentile, Giuseppe Messina, Giuseppe Irrera, Fortunato Morabito
  • Expert Opinion on Investigational Drugs, April 2013, Informa Healthcare
  • DOI: 10.1517/13543784.2013.788643

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication

http://dx.doi.org/10.1517/13543784.2013.788643

The following have contributed to this page: Dr Massimo Martino and Massimo Martino